Mediators of Inflammation

Mediators of Inflammation in Obesity and Its Co-Morbidities


Publishing date
01 Jul 2010
Status
Published
Submission deadline
01 Jan 2010

Lead Editor

1Laboratory of Neuro Endocrine Interactions in Rheumatology and Inflammatory Diseases (NEIRID LAB), Santiago University Clinical Hospital, Research Area, Laboratory 9, 15706 Santiago de Compostela, Spain

2Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA

3Department of Endocrinology and Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, 31008 Pamplona, Spain

4Obesity Biology Research Unit, School of Clinical Sciences, University of Liverpool, Duncan Building, Liverpool L69 3GA, UK


Mediators of Inflammation in Obesity and Its Co-Morbidities

Description

Obesity is a chronic metabolic condition with important public health implications. It is associated with a high risk of cardiovascular disease, insulin resistance, hypertension, and other comorbidities. Several authors have suggested that inflammation may be the link among obesity, type 2 diabetes, cardiovascular disease, and abnormalities of innate and adaptive immune function. Indeed, both clinical and experimental observations demonstrate a strong correlation between systemic markers of inflammation and the most serious comorbidities in obesity.

We invite authors to present original research articles as well as review articles that will stimulate the continuing efforts in defining the role of mediators of inflammation in obesity and related comorbidities. Papers with additional and compelling mechanistic evidence linking the pathogenesis of obesity-related diseases are very welcome.

We are also interested in manuscripts that report the clinical applications of approved or investigational antiobesity drugs with emphasis on efficacy, toxicity, response assessment, multimodality treatment, prognostic factors, and predictive markers.

Potential topics include, but are not limited to:

  • Therapeutic instruments targeting obesity and inflammation in humans
  • Obesity and inflammation integration of metabolic and immune response
  • Obesity, inflammation, and metabolic diseases
  • Cross-talk between adipose tissue and immune system
  • Adipokines in the immune-stress response: impact of weight loss
  • The adipocytes and other cellular mediators in obesity and inflammation
  • The role of TLR and NFkB route in obesity and inflammation
  • Oxidative stress in obesity and diabetes
  • The effect of aging on obesity and inflammatory status
    • Novel inflammation-related adipokines and other adipose tissue-derived inflammatory factors
    • Endoplasmic reticulum stress, hypoxia, and other potential mechanisms underlying inflammation

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/mi/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2010
  • - Article ID 675320
  • - Research Article

Inflammatory Markers in Middle-Aged Obese Subjects: Does Obstructive Sleep Apnea Syndrome Play a Role?

Paschalis Steiropoulos | Nikolaos Papanas | ... | Demosthenes Bouros
  • Special Issue
  • - Volume 2010
  • - Article ID 105489
  • - Research Article

Leptin Inhibits the Proliferation of Vascular Smooth Muscle Cells Induced by Angiotensin II through Nitric Oxide-Dependent Mechanisms

Amaia Rodríguez | Javier Gómez-Ambrosi | ... | Gema Frühbeck
  • Special Issue
  • - Volume 2010
  • - Article ID 170153
  • - Research Article

Human Lipoxygenase Pathway Gene Variation and Association with Markers of Subclinical Atherosclerosis in the Diabetes Heart Study

Kathryn P. Burdon | Megan E. Rudock | ... | Stephen S. Rich
  • Special Issue
  • - Volume 2010
  • - Article ID 367838
  • - Review Article

Functional Food Targeting the Regulation of Obesity-Induced Inflammatory Responses and Pathologies

Shizuka Hirai | Nobuyuki Takahashi | ... | Teruo Kawada
  • Special Issue
  • - Volume 2010
  • - Article ID 513948
  • - Review Article

Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A Review

John N. Fain
  • Special Issue
  • - Volume 2010
  • - Article ID 219583
  • - Review Article

Inflammatory Mediators and Insulin Resistance in Obesity: Role of Nuclear Receptor Signaling in Macrophages

Lucía Fuentes | Tamás Rőszer | Mercedes Ricote
  • Special Issue
  • - Volume 2010
  • - Article ID 359732
  • - Review Article

Role of Heme Oxygenase in Inflammation, Insulin-Signalling, Diabetes and Obesity

Joseph Fomusi Ndisang
  • Special Issue
  • - Volume 2010
  • - Article ID 841343
  • - Research Article

The Effect of Chronic Candesartan Therapy on the Metabolic Profile and Renal Tissue Cytokine Levels in the Obese Zucker Rat

Carolyn M. Ecelbarger | Arjun Rash | ... | Swasti Tiwari
  • Special Issue
  • - Volume 2010
  • - Article ID 495416
  • - Review Article

Peritoneal Adipocytes and Their Role in Inflammation during Peritoneal Dialysis

Kar Neng Lai | Joseph C. K. Leung
  • Special Issue
  • - Volume 2010
  • - Article ID 585989
  • - Review Article

Systemic Inflammation in Chronic Obstructive Pulmonary Disease: May Adipose Tissue Play a Role? Review of the Literature and Future Perspectives

Ruzena Tkacova
Mediators of Inflammation
 Journal metrics
Acceptance rate36%
Submission to final decision53 days
Acceptance to publication29 days
CiteScore6.400
Journal Citation Indicator0.610
Impact Factor4.711
 Submit

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.